Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia

BACKGROUND AND AIMS: Thrombocytopenia is a common hematological abnormality observed in patients infected with hepatitis C virus (HCV). The use of eltrombopag has been approved for HCV-associated thrombocytopenia. This is the first study aiming to determine the predictive factors of response to eltr...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbedewy, Tamer A, Elsebaey, Mohamed A, Elshweikh, Samah A, Elashry, Heba, Abd-Elsalam, Sherief
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375108/
https://www.ncbi.nlm.nih.gov/pubmed/30804674
http://dx.doi.org/10.2147/TCRM.S186106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375108/
https://www.ncbi.nlm.nih.gov/pubmed/30804674
http://dx.doi.org/10.2147/TCRM.S186106

Ejemplares similares